Back to results
US 2026/0053897 A1Published application
Superoxide dismutase and uses thereof for preventing or treating diabetic retinopathy or uveitis
AssigneesGenofocus Co., Ltd., Biomlogic, Inc., Seoul National University Hospital
InventorsJae Gu Pan, Eui Joong Kim, In Ik Chang, Jeong Hyun Kim, Jeong Hun Kim
Life of this patent
Estimating the term…
Abstract
The present invention relates to superoxide dismutase and uses thereof for preventing or treating diabetic retinopathy or uveitis. The superoxide dismutase according to the present invention can be effectively used in the prevention or treatment of diabetic retinopathy or uveitis, particularly through oral administration.
Claims23
A composition for treating, improving or preventing mucositis, comprising a superoxide dismutase (SOD) as an active ingredient.
21-23. (canceled)
Dependencies are inferred from the claim text.